Immix Biopharma, Inc. (IMMX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$8.06
+12.15%
Mkt Cap $668.20M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$0.21 | -$0.27 | -28.57% |
| Q4 2025 Nov 7, 2025 | — | — | — | -$0.19 | -$0.24 | -26.32% |
| Q3 2025 Aug 8, 2025 | — | — | — | -$0.21 | -$0.22 | -4.76% |
| Q2 2025 May 8, 2025 | — | — | — | -$0.23 | -$0.15 | +34.78% |
| Q1 2025 Mar 24, 2025 | — | $96.29K | — | -$0.25 | -$0.16 | +36.00% |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.16 | -$0.24 | -50.00% |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.21 | -$0.15 | +28.57% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.23 | -$0.22 | +4.35% |
| Q1 2024 Mar 29, 2024 | — | $4.78K | — | -$0.23 | -$0.24 | -4.35% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.23 | -$0.23 | +0.00% |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.17 | -$0.24 | -41.18% |
| Q2 2023 May 12, 2023 | — | — | — | -$0.14 | -$0.18 | -28.57% |
| Q1 2023 Mar 27, 2023 | — | -$89.52M | — | -$0.22 | -$0.27 | -22.73% |
| Q4 2022 Nov 9, 2022 | — | — | — | — | -$0.11 | — |
| Q3 2022 Aug 12, 2022 | — | — | — | — | -$0.11 | — |
| Q2 2022 May 13, 2022 | — | — | — | — | -$0.10 | — |
| Q1 2022 Mar 28, 2022 | — | — | — | — | -$3.00 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.06 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.02 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.12 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.10 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.02 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.04 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.04 | — |